Passage Bio (PASG)
(Delayed Data from NSDQ)
$1.20 USD
-0.07 (-5.51%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $1.17 -0.03 (-2.50%) 7:58 PM ET
2-Buy of 5 2
C Value B Growth F Momentum D VGM
Cash flow Statements
Fiscal Year End for Passage Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -102.06 | -136.13 | -185.39 | -112.23 | -45.63 |
Depreciation/Amortization & Depletion | 1.69 | 4.45 | 4.32 | 1.43 | 0.13 |
Net Change from Assets/Liabilities | 5.34 | -8.49 | 11.42 | 14.44 | -5.94 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 16.77 | 21.95 | 42.77 | 15.84 | 11.55 |
Net Cash From Operating Activities | -78.26 | -118.21 | -126.88 | -80.52 | -39.90 |
Property & Equipment | -0.15 | -2.27 | -17.64 | -1.15 | -1.19 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 65.38 | 30.47 | -20.17 | -170.46 | 0.00 |
Other Investing Activities | 0.00 | -3.00 | -8.00 | -0.50 | -0.50 |
Net Cash from Investing Activities | 65.24 | 25.20 | -45.81 | -172.11 | -1.69 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.14 | 0.43 | 166.99 | 228.75 | 176.37 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -1.79 | -0.34 | 0.00 | -0.76 |
Net Cash from Financing Activities | 0.14 | -1.35 | 166.66 | 228.75 | 175.60 |
Effect of Exchange Rate Changes | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -12.89 | -94.36 | -6.04 | -23.87 | 134.01 |
Cash at Beginning of Period | 34.60 | 128.97 | 135.00 | 158.87 | 24.86 |
Cash at End of Period | 21.71 | 34.60 | 128.97 | 135.00 | 158.87 |
Diluted Net EPS | -1.86 | -2.50 | -3.48 | -2.91 | NA |
Fiscal Year End for Passage Bio, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -102.06 | -85.30 | -58.19 | -34.34 |
Depreciation/Amortization & Depletion | NA | 1.69 | 1.73 | 1.09 | 0.88 |
Net Change from Assets/Liabilities | NA | 5.34 | 9.63 | 10.53 | 8.23 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 16.77 | 15.20 | 6.99 | 2.78 |
Net Cash From Operating Activities | NA | -78.26 | -58.75 | -39.59 | -22.45 |
Property & Equipment | NA | -0.15 | -0.13 | -0.13 | -0.03 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 65.38 | 57.77 | 35.32 | 21.24 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | 65.24 | 57.64 | 35.19 | 21.22 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 0.14 | 0.09 | 0.09 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 0.14 | 0.09 | 0.09 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | NA | -12.89 | -1.02 | -4.31 | -1.23 |
Cash at Beginning of Period | NA | 34.60 | 34.60 | 34.60 | 34.60 |
Cash at End of Period | NA | 21.71 | 33.58 | 30.29 | 33.37 |
Diluted Net EPS | NA | -0.30 | -0.49 | -0.44 | -0.63 |